제품별 주사기 및 바늘 시장 규모 및 점유율(주사기, 바늘) 유용성(일회용 및 재사용 가능) 환자 그룹(소아, 성인, 노인); 유형(채혈, 안과, 골수, 카테터); 애플리케이션(일반 외과, 진단, 호흡기, 정형외과, 심혈관, 치과), 최종 사용자(병원, 진료소) - 글로벌 공급 및 수요 분석, 성장 예측, 통계 보고서 2025-2037

Growth engine

• The elderly population is increasing worldwide
• – The global elderly population continues to grow at an exceptional rate, driving demand for injectables. Currently, 8.5% of the world’s population (617 million) is aged 65 and over. Between 2015 and 2050, the number of “older people” aged 80 and over worldwide is expected to more than triple, from 126.5 million to 446.6 million.
• Epidemics and pandemics
• A global disease outbreak that is on the rise – a pandemic is a widespread outbreak of an infectious disease that can significantly increase mortality and morbidity across a wide geographic area and cause significant economic, social, and political disruption. The impact of COVID-19 on pharmaceutical packaging is expected to be high due to the rapid production of vaccines against coronavirus variants. As the epidemic of the disease increases, the need for syringes and needles for the treatment and administration of drugs increases. BD (Becton Dickinson and Company) announced that it has signed an agreement for 2 billion injection products to support the global COVID-19 vaccination initiative in 2021.
• Rapid technological advancements in syringes and needles – 2022 Terumo Pharmaceutical Solutions (TPS) has launched a prefillable polymer syringe for low volume applications such as ophthalmic pharmaceuticals. The PLAJEX 0.5 mL Luer Lock Silicone without Oil Fill Syringe has been specifically developed for demanding low volume prefill syringe (PFS) products, making it ideal for high value drug applications.
• Syringe and
• There are other growth factors in the syringe market such as the surge in VR and AR for needle and syringe manufacturing. Also, the increasing use of prefilled syringes for the treatment of chronic diseases.

challenge

• Increased risk of needlestick injuries – Needlestick injuries (NSIs), which expose healthcare workers to bloodborne pathogens, pose a serious threat to both healthcare workers and patients. These incidents can result in the transmission of a number of bloodborne infectious diseases, especially viruses. These include hepatitis B (HBV), hepatitis C (HCV), and HIV. The Occupational Safety and Health Administration (OSHA) estimates that approximately 5 million healthcare professionals are at risk for occupational exposure to a variety of bloodborne pathogens due to NSIs.
• Increasing adoption of alternative drug delivery technologies
• strict government regulations